Question · asked by 1 review
Pregabalin 300 mg vs placebo: PGIC very much improved
- Population
- adults with moderate or severe pain associated with painful diabetic neuropathy
- Intervention
- Pregabalin 300 mg
- Comparison
- placebo
- Outcome
- PGIC very much improved
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Pregabalin 300 mg vs placebo Patient Global Impression of Change ‐ very much improved · adults with moderate or severe pain associated with painful diabetic neuropathy Pregabalin for neuropathic pain in adults (2019) · Cochrane Headline outcomes only | no estimate extracted | 2 studies · 501 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Pregabalin for neuropathic pain in adults 2019 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.